Literature DB >> 20702551

UK cancer survival statistics.

Valerie Beral, Richard Peto.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20702551     DOI： 10.1136/bmj.c4112

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Primary non-hodgkin lymphoma of lateral skull base mimicking a trigeminal schwannoma: case report.

Authors:  Liu Yang; Wen Li; Min Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.

Authors:  R L Bennett; S J Sellars; S M Moss
Journal:  Br J Cancer       Date:  2011-02-01       Impact factor: 7.640

3.  Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.

Authors:  M P Coleman; D Forman; H Bryant; J Butler; B Rachet; C Maringe; U Nur; E Tracey; M Coory; J Hatcher; C E McGahan; D Turner; L Marrett; M L Gjerstorff; T B Johannesen; J Adolfsson; M Lambe; G Lawrence; D Meechan; E J Morris; R Middleton; J Steward; M A Richards
Journal:  Lancet       Date:  2010-12-21       Impact factor: 79.321

4.  Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data.

Authors:  Laura M Woods; Michel P Coleman; Gill Lawrence; Jem Rashbass; Franco Berrino; Bernard Rachet
Journal:  BMJ       Date:  2011-06-09

5.  Predictors of early death in female patients with breast cancer in the UK: a cohort study.

Authors:  Ceilidh Stapelkamp; Lars Holmberg; Daniela Tataru; Henrik Møller; David Robinson
Journal:  BMJ Open       Date:  2011-11-28       Impact factor: 2.692

6.  Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  A Gentry-Maharaj; E-O Fourkala; M Burnell; A Ryan; S Apostolidou; M Habib; A Sharma; M Parmar; I Jacobs; U Menon
Journal:  Br J Cancer       Date:  2013-10-15       Impact factor: 7.640

7.  A comprehensive assessment of the impact of errors in the cancer registration process on 1- and 5-year relative survival estimates.

Authors:  M J Rutherford; H Møller; P C Lambert
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

8.  Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997-2004.

Authors:  O Dejardin; B Rachet; E Morris; V Bouvier; V Jooste; R Haynes; E G Coombes; D Forman; A P Jones; A M Bouvier; G Launoy
Journal:  Br J Cancer       Date:  2013-02-07       Impact factor: 7.640

9.  Parameter Heterogeneity In Breast Cancer Cost Regressions - Evidence From Five European Countries.

Authors:  Joel Smith; Helen Banks; Harry Campbell; Anne Douglas; Eilidh Fletcher; Alison McCallum; Tron Anders Moger; Mikko Peltola; Sofia Sveréus; Sarah Wild; Linda J Williams; John Forbes
Journal:  Health Econ       Date:  2015-12       Impact factor: 3.046

10.  miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.

Authors:  Baoping Lang; Song Zhao
Journal:  Oncol Rep       Date:  2017-11-01       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.